Conroy Gold and Natural Resources PLC (LON:CGNR) has announced further gold discoveries on its Glenish gold licence in Ireland. In a statement, Conroy said it had identified a new gold-in-soil anomaly and a new gold mineralised outcrop indicating an extension of the Glenish gold target. The new anomaly is 2 kilometres northeast of the Glenish gold target on the border with the Clontibret gold licence.
SigmaRoc PLC (LONM:SRC), the construction materials group, has said it expects to report full-year results that are ahead of current market expectations. The group said the strong trading reported in its December 9, 2020, market update continued through to the end of the year. SigmaRoc expects to report revenues for 2020 of around GBP124mln, up 77% year-on-year, while underlying earnings (EBITDA) are expected to be 54% higher than the year at before at GBP23.8mln.
MaxCyte Inc (LON:MXCT), the cell-engineering and life sciences company, has raised GBP40mln by placing shares at 700p each – a premium to last night’s closing price of 670p. Proceeds from the share subscription will be used to strengthen MaxCyte’s balance sheet to enable the company to accelerate projects in its development pipeline. The newly issued shares represent around 6.9% of the company’s enlarged share capital. Subscribers to the share issue featured a mixture of new and existing investors, including D1 Capital Partners, T. Rowe Price, ArrowMark Partners, Baron Capital Group and First Light Asset Management, alongside existing investors Casdin Capital and Sofinnova Partners.
Argo Blockchain PLC (LON:ARB) said it has taken a 25% stake and become the lead investor in Pluto Digital Assets PLC, a crypto venture capital and technology firm focused on projects in the decentralised technology and finance spaces. The crypto mining firm said it has invested GBP1mln into Pluto at 3p per share as part of an investment round to raise GBP2.5mln. Argo said its contribution was satisfied entirely by the holding of 75,000 Polkadot tokens it had originally purchased in the first quarter of 2019 for US$75,000 (GBP55,163).
Amryt Pharma PLC (NASDAQ:AMYT) (LON:AMYT) said it has signed multi-regional distribution agreements with a company called Medison Pharma. Medison will sell Amryt’s Juxtapid product in Canada and Lojuxta and Myalept in Israel. In a statement, Amryt chief executive, Dr Joe Wiley, said: “Today’s announcement is another positive development as we continue to grow our commercial assets in existing and new territories and we further progress towards our goal of becoming a global leader in rare and orphan diseases.”
IronRidge Resources Ltd (LON:IRR) said it has completed the acquisition of Joy Transporters Ltd, giving it full ownership of the Saltpond and Cape Coast projects in Ghana. The company described the Saltpond and Cape Coast portfolio as a highly prospective ground holding with high priority pegmatite targets. The exploration area is positioned adjacent to IronRidge’s Ewoyaa lithium project, which is host to a 14.5mln tonne mineral resource.
Panther Metals PLC (LON:PALM) said its wholly-owned Aussie subsidiary, Panther Metals Pty, has beefed up its board with two appointments. Ranko Matic and Daniel Tuffin have joined the team down under. Matic is a qualified chartered accountant with more than 30 years’ experience in the areas of financial and executive management, accounting, audit, business and advising companies. Tuffin has a wealth of experience specific to Panther Metals Pty, Panther said.
Sativa Wellness Group Inc (LON:SWEL) has updated investors on appointments to its board, saying Geremy Thomas and George Thomas have both been appointed as directors, with the former becoming its executive chairman. The cannabidiol (CBD) specialist said following a meeting of shareholders on January 26, 2021, Henry Lees-Buckley is no longer its chief executive as of February 3, adding that Geremy Thomas will act as interim CEO until a replacement is appointed.
Cellular Goods PLC, a company producing synthetic cannabinoids products that is understood to be backed by David Beckham’s DB Ventures has announced float plans. Cellular is raising GBP8mln through a share offering that would value it at GBP20mln. Proceeds from the IPO will be used to develop and launch a new range of premium consumer products, prospective investors were told. Cellular said it is aiming to be the London Stock Exchange’s first pure-play consumer CBD brands business.
Bushveld Minerals Limited (LON:BMN) has said it expects to produce around 13%-20% more vanadium in 2021 than in 2020. Group production for 2021 is projected to be between 4,100mln tonnes of vanadium (mtV) and 4,350 mtV. Volumes should be weighted towards the second half of the year due to a 35-day maintenance shutdown at the Vametco plant in South Africa scheduled for the first quarter of the year. As well as the maintenance work, the group will seek to remove certain production bottlenecks at the plant. In a separate announcement, Bushveld revealed that despite cranking out the vanadium at increasing rates during 2020, ore reserves have not reduced significantly, according to the latest mineral resource estimate for the Vametco vanadium mine near Brits on the Western Limb of the Bushveld Complex.
[email protected] Capital PLC (LON:SYME) has said that following the publication of Audited Accounts for the period ended December 31, 2019, and Interim Results for the six months ended June 30, 2020, last week, the company has successfully addressed the technical DTR breach regarding the timing of financial statements. Immediately following publication, [email protected] made a formal request to the FCA for the lifting of the temporary suspension of its Listing and the resumption of dealings in the company’s ordinary shares. The FCA is currently performing the regulatory steps required for the restoration of the listing and re-commencement of dealings. The process has taken longer and is more complex than normal due to the change in accounting reference date, reverse takeover transaction occurring during the period, and multiple financial statements that have been issued. The company also confirmed that no FCA investigation is underway. [email protected] expects to make a further announcement regarding the lifting of the temporary suspension and resumption of dealings in the company’s shares as soon as possible.
Proactive Research has issued a report on SourceBio International PLC (LON:SBI) which has made a huge impact on its return to public markets. Analysts Emma Ulker says: “We estimate that the current scale-up provides a peak capacity for up to GBP9mln revenues per month, prospects for sustained penetration in public and private testing markets, and to cater for evolving testing requirements. Equally, SBI is set to respond to the anticipated tsunami of neglected cases requiring diagnostics, research & development (R&D) support via its Stability Storage segment, and Genomics services, related to non-COVID care once a recovery begins, which should facilitate a turnaround in its other three core divisions.”